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The neurodevelopmental factor dysbindin is required for synapse function and GABA
interneuron development. Dysbindin protein levels are reduced in the hippocampus
of schizophrenia patients. Mouse dysbindin genetic defects and other mouse models
of neurodevelopmental disorders share defective GABAergic neurotransmission and,
in several instances, a loss of parvalbumin-positive interneuron phenotypes. This
suggests that mechanisms downstream of dysbindin deficiency, such as those affecting
GABA interneurons, could inform pathways contributing to or ameliorating diverse
neurodevelopmental disorders. Here we define the transcriptome of developing wild
type and dysbindin null Bloc1s8sdy/sdy mouse hippocampus in order to identify
mechanisms downstream dysbindin defects. The dysbindin mutant transcriptome
revealed previously reported GABA parvalbumin interneuron defects. However, the
Bloc1s8sdy/sdy transcriptome additionally uncovered changes in the expression of
molecules controlling cellular excitability such as the cation-chloride cotransporters
NKCC1, KCC2, and NCKX2 as well as the potassium channel subunits Kcne2 and
Kcnj13. Our results suggest that dysbindin deficiency phenotypes, such as GABAergic
defects, are modulated by the expression of molecules controlling the magnitude and
cadence of neuronal excitability.
Keywords: dysbindin, GABA, parvalbumin, BLOC-1, Neurodevelopmental disorders
INTRODUCTION
Dysbindin is a neurodevelopmental gene product encoded by DTNBP1, a gene whose
polymorphisms influence cognitive and neuroanatomical traits in non-disease individuals. (Straub
et al., 2002; Van Den Bogaert et al., 2003; Bray et al., 2005; Luciano et al., 2009; Markov
et al., 2009, 2010; Mechelli et al., 2010; Cerasa et al., 2011; Tognin et al., 2011; Wolf et al.,
2011; Ayalew et al., 2012; Trost et al., 2013). DTNBP1 polymorphisms have been considered
risk factors for schizophrenia onset (Straub et al., 2002; Van Den Bogaert et al., 2003),
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yet this is not a consensus view (Schizophrenia Working
Group of the Psychiatric Genomics Consortium, 2014; Farrell
et al., 2015). Dysbindin polypeptide expression is reduced in
the brain of schizophrenia affected individuals, in particular
synaptic fields of the hippocampal formation suggesting a
dysbindin requirement for synapse function (Talbot et al.,
2004, 2006, 2011; Tang et al., 2009). Dysbindin’s necessity
for normal synapse architecture and function has been best
documented in dysbindin mutant organisms. The sandy mouse,
a dysbindin null mutation (Bloc1s8sdy/sdy), affects the biogenesis
of synaptic vesicles and impairs glutamatergic and GABAergic
neurotransmission (Jentsch et al., 2009; Ji et al., 2009; Carlson
et al., 2011; Ghiani and Dell’angelica, 2011; Karlsgodt et al.,
2011; Larimore et al., 2011; Mullin et al., 2011; Yuan et al.,
2016). Similarly, Drosophila dysbindin mutants are characterized
by impaired neurotransmission, abrogated synaptic homeostasis,
pre- and post-synaptic morphological alterations, and defects
in short term memory (Dickman and Davis, 2009; Cheli
et al., 2010; Shao et al., 2011; Dickman et al., 2012; Gokhale
et al., 2015a, 2016; Mullin et al., 2015). The reduction of
dysbindin in the hippocampus of patients with schizophrenia,
alterations in excitatory/inhibitory signaling in the mouse, and
changes in neurotransmission impacting short term memory
in Drosophila demonstrate that dysbindin-dependent pathways
provide insight into mechanisms of schizophrenia and other
neurodevelopmental disorders. The focus of this work is the
characterization of these dysbindin-dependent mechanisms and
pathways in the developing mouse brain.
Dysbindin Bloc1s8sdy/sdy mutant possesses impaired
GABAergic neurotransmission, a consequence of decreased
parvalbumin positive interneurons (Ji et al., 2009; Carlson
et al., 2011; Larimore et al., 2014; Yuan et al., 2016). Similarly,
GABA neurotransmission dysfunction has been implicated in
multiple neurodevelopmental disorders including autism and
schizophrenia (Akbarian et al., 1995; Guidotti et al., 2000;
Hashimoto et al., 2003, 2005, 2008a,b; Tabuchi et al., 2007;
Gogolla et al., 2009; Sohal et al., 2009; Chao et al., 2010; Han
et al., 2012; Marin, 2012; Del Pino et al., 2013; Gonzalez-
Burgos et al., 2015; Mariani et al., 2015; Wohr et al., 2015).
The convergence on GABA interneuron defects among
multiple models of neurodevelopmental disorders, including
dysbindin mutants, prompted us to interrogate transcriptional
responses of developing hippocampal neurons bearing null
mutations in dysbindin. We reasoned mechanisms sensitive
to dysbindin mutations would inform us about GABA
response pathways implicated in diverse neurodevelopmental
disorders. Here we describe transcript modifications in the
developing Bloc1s8sdy/sdy hippocampus. The dysbindin
deficiency transcriptome not only captured the previously
described GABA interneuron phenotype but, in addition,
revealed changes in the expression of molecules controlling
cellular excitability such as cation-chloride cotransporters and
potassium channel subunits. Our results suggest that GABAergic
phenotypes in dysbindin deficiency are developmentally
modulated by complex changes in the expression of channels and
transporters controlling the magnitude and tempo of neuronal
excitability.
RESULTS
Null Alleles of the BLOC-1 Subunits
Dysbindin, Muted, and Pallid
Differentially Affect GABAergic
Interneurons
Dysbindin (Bloc1s8) is a subunit of the cytosolic hetero-
octamer known as the biogenesis of lysosome-related organelles
complex 1 (BLOC-1). This complex consists of Bloc1s1–8
subunits (Li et al., 2003; Wei, 2006; Ghiani et al., 2009;
Ghiani and Dell’angelica, 2011). Dysbindin-null Bloc1s8sdy/sdy
mouse hippocampi have reduced numbers of GABAergic
interneurons and diverse interneuron markers resulting in
impaired inhibitory neurotransmission in the hippocampus
(Carlson et al., 2011; Larimore et al., 2014). Here, we explored
the ontological and anatomical penetrance of interneuron
phenotypes in mouse mutants affecting three subunits of
the dysbindin-BLOC-1 complex: dysbindin, muted, and pallid;
which are encoded by the genes Bloc1s8, Bloc1s5, and
Bloc1s6, respectively, in mouse (Larimore et al., 2014). As a
first step, we sought to identify dysbindin-BLOC-1 complex
subunit mutant mouse age and anatomical region with the
most prominent interneuron phenotypes. We then used this
information to identify transcriptional responses to dysbindin-
BLOC-1 dependent impaired inhibitory neurotransmission.
We performed quantitative immunofluorescence microscopy
of parvalbumin-positive interneurons in the hippocampal
formation of adult (P50) wild type and dysbindin-BLOC-
1 null mice: Bloc1s8sdy/sdy, Bloc1s5mu/mu, and Bloc1s6pa/pa
(Figure 1A). We focused on parvalbumin positive cells because
of their abundance in hippocampus as compared to other
interneuron types (Celio, 1986; Tamamaki et al., 2003; Whissell
et al., 2015). In addition, parvalbumin positive interneurons
phenotypes in adult P50 Bloc1s8sdy/sdy hippocampus are shared
with other interneurons, which we previously scored with
diverse GABAergic transcript markers (Larimore et al., 2014).
We determined the numbers of parvalbumin-positive cells in
the dentate gyrus, CA1, and CA3 regions of the hippocampus
and confirmed previously described decreases in CA1 and
CA3 parvalbumin-positive cells in Bloc1s8sdy/sdy (Figure 1B)
(Carlson et al., 2011). These results are also in agreement with
reduced levels of diverse GABAergic interneuron mRNAs in adult
Bloc1s8sdy/sdy hippocampus (Larimore et al., 2014). In contrast,
parvalbumin cell count phenotypes were less pronounced or
absent from the CA1 and CA3 regions of Bloc1s5mu/mu and
Bloc1s6pa/pa (Figures 1A,B). We did not detect changes in
parvalbumin cell counts in the dentate gyrus in any of the
dysbindin-BLOC-1 mutant genotypes analyzed (Figure 1B).
These results indicate that the most severe and anatomically
penetrant GABAergic phenotypes are observed in Bloc1s8sdy/sdy.
In order to define the ontology and anatomical penetrance
of the Bloc1s8sdy/sdy parvalbumin phenotype, we used
quantitative RT-PCR to measure transcripts encoding
GABAergic interneuron markers parvalbumin (Pvalb), the
vesicular GABA transporter (VGAT, Slc32a1), the plasma
membrane GABA transporter GAT2 (Slc6a13), and glutamate
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FIGURE 1 | Differential Effects of BLOC-1 Complex Null Mutations in the Number of Parvalbumin-Positive Neurons. Hippocampal sections from wild
type, Bloc1s8sdy/sdy , Bloc1s5mu/mu, and Bloc1s6pa/pa postnatal day 50 adults were stained with antibodies against parvalbumin and imaged by confocal
microscopy. (A) Depicts sections of the dentate gyrus and CA1 (upper panels) and the CA3 area (bottom panels) for four genotypes. (B) Depicts quantitation of the
number of parvalbumin positive cells per section in each one of the genotypes. Cell counts were performed blind to the genotype of the animal. Wild type (n = 9),
Bloc1s8sdy/sdy (n = 7), Bloc1s5mu/mu (n = 7), and Bloc1s6pa/pa (n = 6) hippocampi analyzed. One Way ANOVA followed by Dunnett’s Multiple Comparison.
decarboxylase 2 (Gad2), an enzyme catalyzing the production
of gamma-aminobutyric acid from L-glutamic acid (Figure 2).
mRNA levels of all of these GABA interneurons markers were
significantly decreased in the hippocampal formation from
embryonic day 18 to 14 days post-natal age (Figure 2A). The
selectivity of these mRNA modifications was determined by
measuring the transcript of synaptophysin (Syp), a globally
expressed synaptic vesicle protein whose transcripts are
insensitive to Bloc1s8sdy/sdy mutation (Larimore et al., 2014). We
reasoned that reductions in GABAergic interneuron function
would be reflected in possible compensatory postsynaptic
changes in the transcripts of chloride channels that control the
inhibitory or excitatory responses of target neurons. NKCC1
and KCC2 are sodium-potassium and potassium-chloride
co-transporters, respectively, whose expression levels determine
whether GABA induces depolarization or hyperpolarization of
target cells (Kaila et al., 2014). Normally, NKCC1 predominates
in immature target neurons whereas KCC2 expression is low
in immature cells (Kaila et al., 2014). This NKCC1 and KCC2
pattern of expression was drastically accentuated in embryonic
18 and newborn Bloc1s8sdy/sdy mouse hippocampus (Figure 2A).
NKCC1 transcripts were increased two- to sixfold in E18
and newborn Bloc1s8sdy/sdy hippocampus. In contrast, the
expression of KCC2 was reduced by several orders of magnitude
in Bloc1s8sdy/sdy hippocampus as compared to age matched wild
type animals (Figure 2A). These Bloc1s8sdy/sdy NKCC1 and
KCC2 expression trends were reverted (NKCC1) or ameliorated
(KCC2) by postnatal day 14, a developmental time where the
chloride electrochemical equilibrium potential reaches adult
levels (Figure 2A) (Berglund et al., 2006; Kaila et al., 2014).
We compared these hippocampal GABA neuron marker and
chloride transporter mRNA phenotypes with expression of these
markers in the prefrontal cortex of embryonic 18 and newborn
wild type and Bloc1s8sdy/sdy (Figure 2B). Prefrontal cortex
has decreased parvalbumin, VGAT, and KCC2 mRNA levels
yet the magnitude of these changes was modest as compared
to the mutant hippocampus (Figure 2B). These data argue
that the most penetrant GABAergic molecular phenotypes
occur in the hippocampus of Bloc1s8sdy/sdy between birth and
postnatal age 14. Furthermore, these Bloc1s8sdy/sdy GABAergic
defects associate with changes in the expression of postsynaptic
chloride channels that determine GABA-dependent excitatory or
inhibitory tone during development.
Transcriptome Analysis of Bloc1s8sdy/sdy
Hippocampus
We performed RNAseq of the hippocampus of wild type and
Bloc1s8sdy/sdy hippocampus at postnatal day seven (Figure 3
and Supplementary Table S1). We selected this age because it
is in between the ages with the most pronounced GABAergic
transcript levels modifications (Figure 2), and it coincides
with peak hippocampal synaptogenesis in mice (Mody et al.,
2001). We prepared normalized polyA cDNA libraries of
three wild type and three Bloc1s8sdy/sdy hippocampi and
determined the abundance of transcripts by Illumina HiSeq2000
sequencing (Mortazavi et al., 2008). Illumina sequencing
quantitation identified 111 transcripts whose content was
significantly modified in Bloc1s8sdy/sdy hippocampi (q < 0.005,
see Supplementary Table S1). Eighty of the transcripts were
upregulated and 31 were downregulated (Figures 3A,B and
Supplementary Table S1). The transcriptome did not detect the
changes in expression of NKCC1 or KCC2 detected by qRT-
PCR (compare Figure 2 and Supplementary Table S1). However,
the transcriptome identified landmark mRNAs that validated
the transcript dataset. First, we found that transcripts encoding
dysbindin (DTNBP1, Bloc1s8) and parvalbumin (Pvalb) were
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FIGURE 2 | Developmental Changes in the Expression of GABA Neuron Markers and Chloride Cotransporters Transcripts in Dysbindin Null
Hippocampus. (A) mRNA was isolated from wild type and Bloc1s8sdy/sdy embryonic day 18, newborn (P0), and postnatal day 14 (P14) hippocampi. Transcripts
were quantified by real time quantitative PCR for the indicated GABA neuron gene products and the chloride transporters NKCC1 and KCC2. (B) Shows a similar
analysis performed in prefrontal cortex. Tissue collections and processing were performed for each age independently, thus qRT-PC comparisons were performed
within a specific age. Wild type values for a transcript were defined as 1 at each specified age. All determinations were performed from at least three animals per
genotype and two independent cDNA preparations for qRT-PCR. Comparisons between wild type and Bloc1s8sdy/sdy were performed with
Wilcoxon–Mann–Whitney Rank Sum Test. All comparisons were significantly different with a p < 0.00041 unless specified otherwise as not significant (NS).
reduced in Bloc1s8sdy/sdy hippocampi by 50% (Figures 3B,D,E
and Supplementary Table S1). Additionally, transcripts of
synaptic vesicle proteins insensitive to the Bloc1s8sdy/sdy mutation
and used as controls, such as synaptophysin and VAMP2, were
not affected by the Bloc1s8sdy/sdy mutation (Figures 3B,C and
Supplementary Table S1) (Larimore et al., 2014). We confirmed
mRNA expression of all of these markers by qRT-PCR in
wild type and Bloc1s8sdy/sdy seven day postnatal hippocampi
(Figure 3F).
We performed gene ontology analysis to prioritize transcripts
associated to pathways and mechanisms for independent
confirmation and further study (Figure 4). We used two
different bioinformatics algorithms, ENRICHR and DAVID,
to statistically assess gene product enrichment within gene
ontological (GO) terms (Huang da et al., 2009; Chen et al.,
2013). The major biological process GO terms associated to
the Bloc1s8sdy/sdy-sensitive transcriptome were Wnt signaling
planar cell polarity (BP GO:2000095, p < 0.00006), excitatory
postsynaptic membrane potential (BP GO:0060079, p< 0.00002)
as well as ontological terms associated to solute transport
and ion permeation through membranes (all p-values <0.0036,
Figure 4A). Similar outcomes were obtained either by analyzing
molecular function GO terms where the top term was channel
activity (MF GO:0015267, p < 0.0027, Figure 4B) or by using
the REACTOME database, where top terms where implicated
in solute transport (R-HSA-425366 and R-HSA-425407, p-
values <0.000032 and <0.00017, respectively, Figure 4C). Gene
ontology analysis using the DAVID algorithm lent the same
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FIGURE 3 | Transcriptome of the Dysbindin Null Developing Hippocampus. (A) Scatter plot of normalized read counts per gene calculated by Cuffdiff analysis
in postnatal seven hippocampi from wild type and Bloc1s8sdy/sdy animals, n = 3. RKBP = reads per kilobase of transcript per million mapped reads. Red dots
represent genes differentially expressed with a q-value <0.05. (B) Volcano plot of Cuffdiff analysis shows (Trapnell et al., 2012) differentially expressed genes in
Bloc1s8sdy/sdy hippocampus as in (A). Red dots correspond to genes with >2 log2-fold differential expression or <-1 log2-fold differential expression. (C–E) Illumina
sequence reads maps for the listed mouse genes from assembly mm9. VAMP2 is a control gene whose expression is not sensitive to Bloc1s8sdy/sdy . (F) Postnatal
day 7 hippocampi were quantified by real time quantitative PCR for the indicated gene products. All determinations were performed from at least three animals per
genotype and three independent cDNA preparations for qRT-PCR. Comparisons between wild type and Bloc1s8sdy/sdy were performed with
Wilcoxon–Mann–Whitney Rank Sum Test. All comparisons were significantly different with a p < 0.0005 unless specified otherwise as not significant (NS).
results as ENRICHR. Ion transport emerged as the top biological
process category (BP GO:0006811 p < 4.29E-04). Gene ontology
categories identified in the Bloc1s8sdy/sdy-sensitive transcriptome
were not recognized within a random brain gene dataset of
comparable size (Figure 4D). Similarly, simultaneous ontology
analyses of the random brain gene data set and the Bloc1s8sdy/sdy-
sensitive transcriptome using the engine GeneCodis showed no
ontology overlap (Tabas-Madrid et al., 2012).
Twelve percent of the 111 transcripts sensitive to Bloc1s8sdy/sdy
belonged to ion transport gene ontology terms. Among these
gene products are those encoded by Fxyd1, Trpm3, Slc39a10,
Slc22a8, Slc24a2, Slc22a6, Slc13a4, Tcn2, Trf, Kcnj13, Kcne2,
Camk2a, and Steap1. We focused on these ion transport gene
products to confirm by qRT-PCR the Bloc1s8sdy/sdy transcriptome
dataset. In total, we chose for confirmation by qRT-PCR 19
of the 111 transcriptome hits. Among these confirmed hits
were Fxyd1, Trpm3, Slc39a10, Slc24a2, Trf, Kcnj13, Kcne2, and
Camk2a, which belong to the ion transport ontology term
(GO:0006811, Figures 5A,B). In addition, we confirmed Cap2,
Chgb, Cpne6, Lynx1, and Mbp; which were selected among gene
products implicated in schizophrenia and neurological disorders
by the DAVID algorithm (p < 2.35E-03, Figure 5C). These
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FIGURE 4 | Ontology Analysis of the Dysbindin Null Developing Hippocampus. Gene ontology analysis of the Bloc1s8sdy/sdy P7 hippocampus using
ENRICHR for (A) biological process, (B) molecular function, and (C) the REACTOME database. (D) Depicts ENRICHR REACTOME analysis for a custom generated
random human brain gene data set presented in Supplementary Table S2.
results validate the Bloc1s8sdy/sdy hippocampal transcriptome
dataset by means of an ontological prioritization of mRNA
phenotypes.
NCKX2, which is encoded by Slc24a2 is the most significantly
reduced transcript in Bloc1s8sdy/sdy hippocampus (Figure 5).
NCKX2 is a sodium-potassium-calcium exchanger that regulates
calcium transients and excitability (Lee et al., 2002; Jeon
et al., 2003; Kim et al., 2005; Stephan et al., 2011). Kcnj13
and Kcne2 are the most significantly upregulated transcripts
in Bloc1s8sdy/sdy hippocampus (Figure 6A). We focused our
studies in these potassium channels as they may represent
compensatory mechanisms secondary to impaired GABAergic
neurotransmission in Bloc1s8sdy/sdy brain. Kcnj13 is an inward
rectifier potassium channel, also known as Kir7.1, whereas Kcne2
or MiRP1 is a voltage gated potassium channel modulatory
subunit. Loss of any one of these two channel subunits
results in increased membrane excitability both in neurons
and muscle cells (Ying et al., 2012; Abbott et al., 2014;
McCloskey et al., 2014). Illumina sequencing digital quantitation
of these two transcripts showed that Kcnj13 increased threefold
while Kcne2 increased 4.5-fold in mutant hippocampus as
compared to controls (Figures 6A,B). We confirmed these
Bloc1s8sdy/sdy mRNA changes by qRT-PCR and found that
Kcnj13 and Kcne2 increased their expression by 9.6- and 10.5-
fold, respectively, in postnatal day seven mutant hippocampus
(Figure 6C). These changes in mRNA led to increased protein
expression. We measured protein levels of Kcne2 polypeptide
in postnatal day 50 wild type and mutant hippocampus.
We focused on Kcne2 because antibodies recognized bands
of the proper molecular weight, which were abolished by
preincubating antibodies with the antigenic Kcne2 peptide
(Figures 6D,E). We used as loading controls actin and the
mitochondrial chaperone mortalin (Hspa9) and as positive
controls dysbindin (Bloc1s8) and the GABA vesicular transporter
(Vgat) (Figures 6D,E). Protein levels of Kcne3 increased by
two- to threefold in mutant hippocampus (Figures 6D,E).
Since these immunoblots were performed in young adult
hippocampus, postnatal day 50, these results demonstrate that
increased expression of a potassium channel subunit that
decreases excitability is persistent phenotypes downstream of
Bloc1s8sdy/sdy. We propose that changes in the expression
of NKCC1, KCC2, NCKX2, Kcne2, and Kcnj13 represent
developmental adaptive responses to a reduced GABAergic
tone induced by genetic defects in a neurodevelopmental gene,
Bloc1s8.
DISCUSSION
We described GABA neuron defects and transcriptional
responses downstream of a mutation in a neurodevelopmental
gene product, dysbindin, encoded by DTNBP1 and Bloc1s8
in human and mice, respectively. We identified two novel
molecular phenotypes in dysbindin deficiency (Figure 7). First,
we found drastic changes in the expression of the cation-
chloride cotranspoters NKCC1 and KCC2 during hippocampal
development. These NKCC1 and KCC2 expression ratio changes
are similar to those described in schizophrenia patient brains
where the NKCC1 and KCC2 expression ratio is increased (Hyde
et al., 2011; Sullivan et al., 2015). Second, the transcriptome
of Bloc1s8sdy/sdy postnatal day 7 hippocampus is enriched in
transcripts implicated in ionic regulation. In particular, one of
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FIGURE 5 | Dysbindin null developing hippocampus changes the expression of ion transport gene products. (A) Volcano plot of Cuffdiff analysis (Trapnell
et al., 2012) shows differentially expressed genes in Bloc1s8sdy/sdy hippocampus as in Figure 3B. Arrows mark genes belonging the ion transport ontology terms
and neurological disorder according to DAVID analysis. (B,C) Postnatal day 7 hippocampi mRNA were quantified by real time quantitative PCR for the indicated gene
products belonging to ion transport ontology terms (B) and neurological disorder (C). All determinations were performed from at least three animals per genotype
and three independent cDNA preparations for qRT-PCR. Comparisons between wild type and Bloc1s8sdy/sdy were performed with Wilcoxon–Mann–Whitney Rank
Sum Test. All comparisons were significantly different with a p < 0.005.
the most prominently downregulated messages was SLC24A2
which encodes the sodium-potassium-calcium exchanger 2 or
NCKX2. Loss of NCKX2 protein or its transport function
increases cytoplasmic calcium levels, thus prolonging the tempo
of cellular excitability (Lee et al., 2002; Jeon et al., 2003;
Kim et al., 2005; Stephan et al., 2011). In contrast, we found
that two of the most upregulated messages in Bloc1s8sdy/sdy
hippocampus encode potassium channel subunits Kcne2 and
Kcnj13. We documented increased expression of the message and
protein expression of Kcne2, an ancillary regulatory potassium
channel subunit in the hippocampus of postnatal day 7 and
adult Bloc1s8sdy/sdy animals. Loss of Kcne2 or Kcnj13 increase
cellular excitability (Ying et al., 2012; Abbott et al., 2014;
McCloskey et al., 2014), thus our findings suggest that their
overexpression in Bloc1s8sdy/sdy hippocampus may decrease
cellular excitability.
The transcriptome of Bloc1s8sdy/sdy hippocampus identified
reduced expression of Bloc1s8, Pvalb, and 111 additional
transcripts, yet it did not detect modifications in the expression
of NKCC1 and KCC2 transcripts documented here by qRT-
PCR. Similarly, the transcriptome did not detect changes in the
expression of the copper homeostasis molecules Atp7a, Atox1,
and Lox; as well as other GABA neuron markers previously
documented by us (Larimore et al., 2014; Gokhale et al., 2015b).
This argues that our transcriptome either was not sufficiently
powered to identify all transcripts sensitive to the Bloc1s8sdy/sdy
mutation in the developing hippocampus or the depth of
library sequencing was insufficient. However, the transcriptome
still illuminated new ion channel and transport mechanisms
secondary to the Bloc1s8sdy/sdy mutation. A compromised
discovery of transcripts sensitive to the Bloc1s8sdy/sdy allele may
be a contributing factor to explain why the transcriptome gene
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FIGURE 6 | Dysbindin null developing hippocampus changes the expression of potassium channel subunits. (A) Volcano plot of Cuffdiff analysis shows
(Trapnell et al., 2012) differentially expressed genes in Bloc1s8sdy/sdy hippocampus as in Figure 3B. Arrows mark potassium channel subunit genes for reference.
(B) Illumina sequence reads maps for the listed genes from assembly mm9. (C) Postnatal day 7 hippocampi mRNA were quantified by real time quantitative PCR for
Kcne2 and Kcnj13. All determinations were performed from at least three animals per genotype and three independent cDNA preparations for qRT-PCR.
Comparisons between wild type and Bloc1s8sdy/sdy were performed with Wilcoxon–Mann–Whitney Rank Sum Test. All comparisons were significantly different with
a p < 0.0001. (D,E) Immunoblot analysis of Kcne2 expression in wild type and Bloc1s8sdy/sdy hippocampus P50 adult hippocampus in the absence or presence of
the Kcne2 antigenic peptide. Control blots with dysbindin antibodies (Bloc1s8), Vgat and loading controls (actin and Hspa9) are presented. (E) Comparisons
between actin and other antigens were performed Kruskal–Wallis Rank Sum Test followed by pairwise Wilcoxon–Mann–Whitney Rank Sum Test.
ontology poorly overlaps with the ontology of the Bloc1s8sdy/sdy
and the BLOC-1-sensitive proteomes (Gokhale et al., 2016).
An additional factor to account for the poor overlap between
ontologies of the proteome and transcriptome in Bloc1s8sdy/sdy
genetic defects is the relative protein abundance of channels and
transporters as compared to other proteins. For example, beta
actin is present in 114 million copies per HeLa cell. In contrast,
NKCC1 is present in ∼100,000 copies per HeLa cell while the
Arp2/3 complex is present in 2 million copies per cell (Itzhak
et al., 2016). We found that the Arp2/3 complex is downregulated
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FIGURE 7 | A model of phenotypes downstream of GABA interneurons
in dysbindin null developing hippocampus. Diagram depicts a model of
wild type and Bloc1s8sdy/sdy neuron innervated by parvalbumin-positive
GABA terminals (blue triangles) at postnatal day 7. The Bloc1s8sdy/sdy
mutation decreases the number of GABA cells and synapses (reduced blue
triangles). Changes in the expression of NKCC1, KCC2, and NCKX2 are
represented by the size of the circle. Arrows depict direction of ion flows. The
shade of gray represents predicted intracellular chloride concentration, note
an increased concentration of intracellular chloride in Bloc1s8sdy/sdy neurons
due to changes in expression in transporters expression.
by proteomics in dysbindin mutations and that the Arp2/3
complex genetically and biochemically interacts with dysbindin
(Gokhale et al., 2016). Thus, the Bloc1s8sdy/sdy transcriptome
likely contributes hits that escape the partial coverage and
comparative sensitivity afforded by proteomic studies. It is
interesting that adding the Bloc1s8sdy/sdy transcriptome hits
to the BLOC-1 sensitive proteome hits minimally modifies
the gene ontology terms associated to the BLOC-1 sensitive
proteome (Supplementary Figure S1). In contrast, ionic channel
ontology terms discovered with the Bloc1s8sdy/sdy sensitive
transcriptome are no longer top priority when added to the
BLOC-1 sensitive proteome. Thus, proteome and transcriptome
gene ontologies associated to Bloc1s8sdy/sdy are complementary
in the identification of mechanisms that require dysbindin or
compensate Bloc1s8 genetic defects.
How can we reconcile that loss of dysbindin during
development modifies the expression of molecules with apparent
opposite roles in excitability? On one hand, the Bloc1s8sdy/sdy
mutation would increase neuronal excitability by changes in
NKCC1, KCC2, and NCKX2 expression (Figure 7). On the
other hand, dysbindin mutation would increase the expression
of potassium channel subunits (Kcne2 and Kcnj13), which
would decrease neuronal excitability. We favor a model where
pro-excitatory changes in the expression of NKCC1, KCC2, and
NCKX2 would be confined to a cell type in the developing
hippocampus distinct from cells where increased expression
Kcne2 and Kcnj13 occurs (Figure 7). Increase expression of
the potassium channel ancillary subunit Kcne2 is predicted
to decrease neuronal excitability based on the functional
consequences of Kcne2 mutation in excitable tissues (Ying et al.,
2012; Abbott et al., 2014; McCloskey et al., 2014). Mutations
in KCNE2 in human heart causes a long QT-syndrome and
ventricular fibrillation by diminishing potassium currents while
mouse null mutations in Kcne2 increase the excitability of cortical
pyramidal neurons (Abbott et al., 1999, 2014). However, the
function of Kcne potassium channel subunits is more nuanced.
Overexpression of Kcne2 could influence diverse potassium
channels at the level of gating, selectivity, conductivity, and
channel traffic such as their movement along the exocytic route,
endocytosis, and channel polarized cell distribution. (McCrossan
and Abbott, 2004; Kanda et al., 2011a,b,c; Abbott, 2015). Some of
these properties associated to Kcne2 family members could occur
in the same cells where the expression of NKCC1 and KCC2 is
modified as a way to modulate the frequency of GABA excitatory
potentials in developing hippocampus.
Increased NKCC1, and decreased KCC2 and NCKX2
expression changes in Bloc1s8sdy/sdy hippocampus are more
pronounced between post-natal days 0 to 7, a time where
GABA neurotransmission is excitatory due to high intracellular
concentration of chloride (Berglund et al., 2006; Ben-Ari
et al., 2007; Kaila et al., 2014). We speculate that the increased
expression of NKCC1 and the drastically reduced expression of
KCC2 would increase intracellular chloride concentrations in
developing P7 hippocampal Bloc1s8sdy/sdy neurons (Figure 7).
An increased intracellular chloride concentration would in
turn compensate the reduction in parvalbumin-positive cells by
increasing depolarizing responses to GABA neurotransmission
in Bloc1s8sdy/sdy hippocampus (Figure 7). Although this model
is speculative, we believe it is of importance. The function of
NKCC1 and/or KCC2 can be inhibited by the FDA approved
drugs bumetanide and furosemide, respectively (Loscher
et al., 2013). Bumetamide has been used to revert persistently
increased intracellular chloride concentrations in a mouse
model of Down syndrome and improve cognitive outcomes
(Deidda et al., 2015). This observation raises the prospect of
NKCC1 inhibitors as developmental modulators of GABAergic
neurotransmission in Bloc1s8sdy/sdy and other disorders of
GABAergic neurotransmission such as schizophrenia. However,
if as we postulate here, increased NKCC1 expression in the
developing Bloc1s8sdy/sdy hippocampus is a compensatory
mechanism for reduced GABAergic innervation, then
bumetanide may be ineffective or have deleterious effects in
Bloc1s8sdy/sdy and other neurodevelopmental genetic defects
affecting GABA neurotransmission such as schizophrenia. In
fact, chronic inhibition of NKCC1 with bumetanide during
development induces endophenotypes that resemble those
in schizophrenia and the Bloc1s8sdy/sdy mutation (Wang and
Kriegstein, 2011). Bumetanide is ineffective in treating positive
and negative symptoms in schizophrenia patients (Rahmanzadeh
et al., 2016). However, inhibition of KCC2 during development
may be an effective strategy to ameliorate neurodevelopmental
disorders with impaired GABA neurotransmission. Our
findings indicate that the GABA neurotransmission defects
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observed in Bloc1s8sdy/sdy mice offer a model to study the
functional and anatomical consequences of modulating GABA
neurotransmission and cellular excitability by pharmacological
agents that target potassium channels and cation transporters
that modulate intracellular chloride and calcium concentration.
MATERIALS AND METHODS
Antibodies
Antibodies utilized in this study: rabbit anti-parvalbumin
(ThermoFisher Scientific PA1-933), mouse anti-synaptophysin
(EMD Millipore MAB5258), mouse anti-actin-beta (Sigma
A5451), mouse anti-Hspa9/mortalin (NeuroMab N52A/42),
rabbit anti-Bloc1s8 (gift from Dr. Talbot), mouse anti-Vgat
(Synaptic Systems 131011), and rabbit anti-Kcne2 (Alomone
APC-054).
Animals and Tissue Preparation
Mice null for dysbindin (Bloc1s8sdy/sdy), muted (Bloc1s5mu/mu)
and pallidin (Bloc1s6pa/pa) were previously described (Larimore
et al., 2014). Mice were bred in-house following IUCAC approved
protocols. All animals were in in the C57/Black6 background
qRT-PCR
Hippocampal regions were dissected from E18 to P14 and
young adult animals between P48-P52 then flash frozen. mRNA
was isolated using TRIzol (Invitrogen Life Technologies, Grand
Island, NY, USA) extraction and then reverse transcribed into a
cDNA using Super Script III First-Strand Synthesis (Invitrogen
Life Technologies, Grand Island, NY, USA). Quantitative PCR
amplifications were performed on a LightCycler480 Real Time
plate reader using Light Cycler 480 SYBR Green reagents (Roche,
Indianapolis, IN) at 95◦C for 5 min followed by 45 cycles of 95◦C
for 5 s, 65◦C for 10 s, and 72◦C for 20 s followed by a 95◦C for
5 s, 65◦C for 2 min and a 97◦C incubation to determine melting
curves. Supplementary Primers Table describes the primers used
in this study (Supplementary Primers Table S1).
Immunofluorescence Labeling for
Confocal Microscopy
Brain slices were prepared from adult mice at P50 as described
(Larimore et al., 2011; Larimore et al., 2013). Following ketamine
treatment, animals were transcardially perfused with Ringer’s
solution and then perfused with fixative (4% paraformaldehyde
with 0.1% glutaraldehyde). For 12-18 h, brains were post-fixed
in 4% paraformaldehyde. Following post-fixation, brains were
cut into 60 µm thick sections and stored in antifreeze (0.1 M
sodium phosphate monobasic, 0.1 M sodium phosphate dibasic
heptahydrate, 30% ethylene glycol, 30% glycerol) at –20◦C.
Brain sections containing the hippocampus were incubated
in 1% sodium borohydride. For 60 minutes, tissue was pre-
incubated (5% NHS and 1% BSA and 0.3% Triton X-100).
Tissue was incubated in primary antibody overnight (anti-
Parvalbumin 1:200 with anti-Synaptophysin 1:10,000, 1% NHS
and 1% BSA) followed by 60 min in a secondary antibody
(1% NHS and 1% BSA 1:500 anti-mouse 568 and anti-rabbit
488) (Invitrogen Molecular Probes, Carlsbad, CA, USA). Finally,
tissue was incubated for 30 min in cupric sulfate (3.854 W/V
Ammonium Acetate, 1.596 W/V Cupric Sulfate, pH 5). Tissue
sections were mounted on slides with Vectashield (Vector
Laboratories). Confocal microscopy of immunofluorescent
samples was performed with an Anxiovert 100M (Carl Zeiss)
coupled to an Argon laser, HeNe1 laser, and Titanium Sapphire
laser. Z-stacks were acquired using Plan Apochromat 20X/0.5
dry objective. The emission filters used for fluorescence imaging
were BP 505–530 and LP 560. Images were acquired with ZEN
(Carl Zeiss). Parvalbumin-positive cells were scored by creating
a region of interest (ROI) for each region of the hippocampus.
Experimenters were blinded to which genotype was analyzed
and the intensity of fluorescence in the section was not taken
into account for scoring. Cells were considered parvalbumin-
positive if the cell body and dendrites were distinguishable from
the surrounding fluorescence in the ROI. More than one blind
experimenter scored each genotype and each region. For each
experiment, a minimal of four control hippocampi and four null
hippocampi were processed independently.
Immunoblot Analyses
Brain lysates were separated for SDS–PAGE and transferred to
PVDF membranes (BioRad, Hercules, CA, USA). Membranes
were probed with primary antibodies followed by HRP-
conjugated anti-rabbit and anti-mouse secondary antibodies
(Santa Cruz Biotechnology, Santa Cruz, CA, USA and
Invitrogen). Secondary antibodies were detected using
Supersignal West Dura Extended Duration or Western Lightning
substrate (Pierce Chemical, Rockford, IL, USA and Perkin Elmer)
and developed on film. Quantitation was performed as follows,
multiple film exposures were obtained and those films within
a liner range were used for quantitation using Fiji (Schindelin
et al., 2012). Antigen expression was compared to actin and
Hspa9 as housekeeping gene products.
Transcriptomic and Gene Ontology
Analysis
RNAseq services were contracted from Otogenetics Corporation
(Atlanta, GA, USA). Briefly, RNA from P7 control and dysbindin
mutant hippocampi were extracted with Trizol Reagent and
polyA RNA was isolated. The integrity and purity of RNA
were determined with Agilent Bioanalyzer. cDNA was prepared
with Clontech SmartPCR cDNA kit (Clontech Laboratories).
cDNA fragmentation was done with Covaris shearing, profiled
with Agilent Bioanalyzer, and subjected to Illumina library
preparation with NEB Next reagents (New England Biolabs).
RNA content per sample was normalized with ERCC Spike-
in (Ambion Thermo Fisher Scientific). The quality, quantity as
well as size span of Illumina libraries were determined with an
Agilent Bioanalyzer. The libraries were sequenced with Illumina
HiSeq2000 sequencing according to standard procedures with a
minimum number of 20 million reads per sample. Sequencing
data sets from illumina HiSeq2000 were mapped with Tophat
(v2.0.5) against reference assembly UCSC mm9. Mapping from
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Tophat were analyzed by cuﬄinks.cuffdiff (v.2.0.2), to measure
expression level (Trapnell et al., 2012). Expression levels were
measured with RPKM (Reads Per Kilobase per Million mapped).
q-value less than 0.05 was considered as statistically significant.
Data are accessible upon request through DNANexus.
We used three algorithms to perform gene ontology analysis:
GeneTerm Linker1 (Fontanillo et al., 2011), ENRICH2 (Chen
et al., 2013), and Database Annotation, Visualization and
Integrated Discovery3 (DAVID) (Huang da et al., 2009). Briefly
gene lists uploaded to DAVID were analyzed by setting
annotations based by species (Huang da et al., 2009). Parameters
for these functional annotation charts included P-value cutoff
(<0.01), a minimum number of three genes for each GO
term, fold enrichment, Bonferroni, and/or Benjamini corrected
statistical analysis to control for false discovery (Huang da et al.,
2009).
The Bloc1s8sdy/sdy-sensitive transcriptome was compared
against a brain enriched random gene data with ENRICHR
algorithm described above. We selected the top 100 genes
expressed in hippocampus, caudate, and cortex from http:
//www.gtexportal.org/home/ (Supplementary Table S2)
(The GTEx Consortium, 2013, 2015). Three hundred
top expressed genes were randomized using the Excel
function = RANDBETWEEN(1,n) and the first 150 genes
were selected in block for gene ontology analyses. None of the
ontology terms in GO BP, MF, and the REACTOME database
were common between the Bloc1s8sdy/sdy-sensitive transcriptome
gene dataset and the brain random dataset. We further confirmed
the lack of overlap in gene ontology terms between the random
brain gene data set and the Bloc1s8sdy/sdy-sensitive transcriptome
with GeneCodis, and engine that allows for the comparison of
two datasets simultaneously (Tabas-Madrid et al., 2012).
Statistical Analysis
Experimental conditions were compared using Synergy Kaleida-
Graph, version 4.1.3 (Reading, PA) or Aabel NG2 v5 x64
by Gigawiz as specified in each figure. Transcriptomic
data were processed by the cuﬄinks.cuffdiff (v.2.0.2) which
corrected for multiple comparisons using Benjamini–
Hochberg procedure. These values are expressed as q-values




in the transcriptome at a q threshold of 0.05 and marked as yes
in Supplementary Table S1. qRT-PCR results were subjected to
tests specified in each figure legend without multiple comparisons
corrections.
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FIGURE S1 | Ontology analysis of the BLOC-1 sensitive proteome with or
without addition of the Bloc1s8sdy/sdy hippocampus transcriptome. Gene
ontology analysis of the BLOC-1 sensitive proteome using the Geneterm Linker
algorithm was performed with and without addition of the Bloc1s8sdy/sdy P7
hippocampus transcriptome hits. The numbers in the Z axis represent the gene
ontology term groups defined by Geneterm Linker as metagroups (Fontanillo
et al., 2011). The internal tightness of each metagroup and its separation from
other metagroups is defined by the Silhouette score. Strong tightness between
terms within a metagroup is defined by a positive Silhouette score.
TABLE S1 | Cufflinks Analysis of Bloc1s8-null Transcriptome.
TABLE S2 | Brain Enriched Randomized Gene Set.
PRIMERS TABLE S1 | Primer list for qRT-PCR experiments.
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